-
Better Buy: Johnson & Johnson vs. Pfizer Inc.
Post on 12/9/16
-
Oscar Center Opens in Downtown Brooklyn
Post on 12/8/16
-
Ohr Pharmaceutical Prices $7.75M Public Offering of Common Stock
Post on 12/8/16
-
Why You Should (and Shouldn't) Buy Celldex Therapeutics, Inc.
Post on 12/8/16
-
Why Celldex Rallied 22% In November
Post on 12/8/16
-
Better Buy: Amgen Inc. vs. Pfizer
Post on 12/8/16
-
Is Pfizer's New PD-L1 Drug a Game-Changer?
Post on 12/8/16
-
Better Buy: Johnson & Johnson vs. Eli Lilly
Post on 12/8/16
-
Simpson Healthcare Executives Honored as 2016 eHealthcare Leadership Awards Winner at the 20th Annual Healthcare Internet Conference
Post on 12/7/16
-
Zoetis Announces Authorization of $1.5 Billion Share Repurchase Program
Post on 12/6/16
-
Read This Before You Buy Biotech Stocks
Post on 12/6/16
-
The Main Reason Achillion Pharmaceuticals, Inc. Collapsed 34% in November
Post on 12/6/16
-
Here's Why Regeneron Pharmaceuticals, Inc. Jumped 9.4% in November
Post on 12/6/16
-
Cigna Earns Top Marks in 2017 Corporate Equality Index for 5th Consecutive Year
Post on 12/5/16
-
Regeneron's CEO Blasts Peers on Innovation
Post on 12/5/16
-
Forget Pfizer: Here Are 3 Better Dividend Stocks
Post on 12/5/16
-
Why Bristol-Myers Squibb Co. Stock Surged in November
Post on 12/5/16
-
Does Pfizer Pass Warren Buffett’s Test?
Post on 12/5/16
-
This Trump Appointment Likely Spells Imminent Doom for Obamacare
Post on 12/5/16
-
Retro Fitness Expands Florida Footprint through Franchising
Post on 12/4/16
-
Agile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding
Post on 12/1/16
-
What's Pfizer's Excuse for Not Buying Exelixis?
Post on 12/1/16
-
Merck Boosts Dividend 2% And Has Several Key Growth Drivers
Post on 11/30/16
-
J&J - Approaching Value Territory, But I Am Not Waiting
Post on 11/30/16
-
Celgene Stock Split: Is the Biotech Ready to Split Again?
Post on 11/29/16
New York
